145 related articles for article (PubMed ID: 22045619)
1. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Italiano A; Cioffi A; Penel N; Levra MG; Delcambre C; Kalbacher E; Chevreau C; Bertucci F; Isambert N; Blay JY; Bui B; Antonescu C; D'Adamo DR; Maki RG; Keohan ML
Cancer; 2012 Jul; 118(13):3330-6. PubMed ID: 22045619
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
5. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
[TBL] [Abstract][Full Text] [Related]
6. A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status.
Im CK; Rha SY; Jeung HC; Jeong J; Lee SH; Noh SH; Roh JK; Chung HC
Oncology; 2009; 77(6):349-57. PubMed ID: 20016228
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
[TBL] [Abstract][Full Text] [Related]
8. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
11. A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
Hersh EM; O'Day SJ; Ribas A; Samlowski WE; Gordon MS; Shechter DE; Clawson AA; Gonzalez R
Cancer; 2010 Jan; 116(1):155-63. PubMed ID: 19877111
[TBL] [Abstract][Full Text] [Related]
12. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
Socinski MA; Schell MJ; Bakri K; Peterman A; Lee JH; Unger P; Yates S; Hudgens S; Kies MS
Cancer; 2002 Sep; 95(6):1265-73. PubMed ID: 12216094
[TBL] [Abstract][Full Text] [Related]
13. Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome.
Penel N; Italiano A; Ray-Coquard I; Chaigneau L; Delcambre C; Robin YM; Bui B; Bertucci F; Isambert N; Cupissol D; Bompas E; Bay JO; Duffaud F; Guillemet C; Blay JY;
Ann Oncol; 2012 Feb; 23(2):517-23. PubMed ID: 21566149
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of taxane regimens in patients with metastatic angiosarcoma.
Hirata T; Yonemori K; Ando M; Hirakawa A; Tsuda H; Hasegawa T; Chuman H; Namikawa K; Yamazaki N; Fujiwara Y
Eur J Dermatol; 2011; 21(4):539-45. PubMed ID: 21697045
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
Kim HS; Kim JW; Wu HG; Chung HH; Park NH; Song YS; Kang SB; Lee HP
J Obstet Gynaecol Res; 2010 Jun; 36(3):598-604. PubMed ID: 20598043
[TBL] [Abstract][Full Text] [Related]
17. Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.
Lu CH; Lin YC; Chang HK
Chang Gung Med J; 2007; 30(1):33-40. PubMed ID: 17477027
[TBL] [Abstract][Full Text] [Related]
18. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
[TBL] [Abstract][Full Text] [Related]
19. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
Rossi D; Graziano F; Luzi Fedeli S; Fedeli A; Alessandroni P; Catalano V; Giordani P; Testa E; Catalano G
Minerva Med; 2002 Aug; 93(4):303-7. PubMed ID: 12207200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
